Two years ago, paying less than $300/month for semaglutide felt like a coup. In mid-2026, supervised programs advertise $49/month on annual plans and $147/month tablets, and the ads keep undercutting each other. Something structural changed. Here's what, and how to spend it wisely.
Key Takeaways
- The 2026 price collapse is real: telehealth competition, maturing compounding capacity, and cheaper patient acquisition have compressed margins across the board.
- Commitment-tier pricing (month-to-month vs. annual) is the main mechanism — the headline $49 price is real but buys a 12-month commitment.
- Ride the war by comparing total 12-month cost, not headline price — and never let price outrank pharmacy quality and clinical supervision.
- Below the legitimate market band, cheap stops being a deal: sub-market pricing comes out of sourcing, testing, or supervision.
Why Prices Collapsed
Three forces stacked. Competition: dozens of well-funded telehealth brands are fighting over the same searches, and price is the easiest lever to pull in an ad. Capacity: compounding pharmacies scaled hard through 2024–2025; the production cost of a monthly semaglutide supply is a fraction of what patients were paying, leaving room to cut. Retention economics: platforms realized a patient kept for two years at a thin margin beats one who quits at month four over cost — hence the aggressive annual-commitment pricing designed to lock in the long game.
The Commitment-Tier Mechanic
The signature 2026 structure looks like this:
| Plan | Typical monthly price | The catch |
|---|---|---|
| Month-to-month | $179–$249 | None — full flexibility |
| 3-month commitment | $120–$149 | Billed upfront or committed |
| 6-month commitment | $99–$119 | Mid-term flexibility trade |
| 12-month commitment | $49–$99 | You're marrying the provider for a year |
The annual price is genuine, but read the commitment terms: what happens if you stop responding to the medication, get pregnant, or the provider's service degrades? The right answer is a documented medical-exit policy. Ask before you commit, in writing.
How to Actually Capture the Savings
- Compare 12-month totals, including first-month promos expiring into higher renewals.
- Date before marrying: run one or two month-to-month cycles with a provider — test shipping, support, and product consistency — then convert to the annual rate.
- Recheck the market every renewal. The war is ongoing; last year's great rate is this year's mediocre one.
- Hold the quality line: named compounding pharmacy, real clinical follow-up, verifiable licenses. A price that requires giving those up isn't a price — it's a warning.
Where the Best Current Deals Sit
Telos Rx — Semaglutide
Compounded semaglutide — from $49/mo on 12-month plans
Flat pricing regardless of dose, with month-to-month through annual commitment tiers.
Compounded medications are not FDA-approved.
Visit Telos Rx Paid linkWellorithm
Oral tablets — sema $147/mo, tirz $249/mo
The lowest published oral compounded pricing we currently track.
Compounded medications are not FDA-approved.
Visit Wellorithm Paid linkEden
Oral drops + gummies — sema $249/mo ($149 first month)
Oral compounded formats including drops and gummies, with a discounted first month.
Compounded medications are not FDA-approved.
Visit Eden Paid linkPrice wars end eventually — capacity consolidates, ad costs rise, regulation shifts. Lock in supervised care at war pricing while the shooting continues, and keep your standards while you do it.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.